The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 43 | — | 20.1x | Near average | |
Growth | 60 | 351.5% | 5.6% | Near average | |
Quality | 92 | 42.8% | 7.6% | Above average | |
Safety | 27 | 1.0x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
ImmunityBio, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy ImmunityBio, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The price target analysis for ImmunityBio shows a state of complete stability in analyst estimates over the periods (1, 7, 30 days), where the average price target settled at 13 dollars, representing a significant premium compared to the current price of 7.22 dollars. However, these estimates remain based on very limited coverage from only one analyst, which raises the levels of uncertainty regarding the general market consensus and makes the Dispersion statistically unmeasurable in an accurate manner.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.